There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
The stock, which is currently worth 2021 to 276.5 times its sales, is clearly overvalued in comparison with peers.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The tendency within the weekly time frame is positive above the technical support level at 71800 KRW
Stock prices approach a strong long-term resistance in weekly data at KRW 98600.
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
The company has insufficient levels of profitability.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
With an expected P/E ratio at 81.9 and 18.81 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.